Five Georgia State Graduate Business Programs Ranked in 2025 U.S. News Rankings
Five Georgia State Graduate Business Programs Ranked in 2025 U.S. News Rankings
Atlanta, Georgia, April 08, 2025 (GLOBE NEWSWIRE) -- The part-time MBA and specialty programs in information systems, real estate, business analytics, and healthcare management offered by Georgia State University's J. Mack Robinson College of Business are ranked in U.S. News & World Report's 2025 Best Graduate Schools, released today (April 8).
Robinson's graduate program in information systems is No. 7 among public university programs and No. 10 overall. It is offered as an M.S. in Information Systems and as an MBA concentration.
The college's graduate program in real estate is No. 9 among public university programs and No. 17 overall. It is offered as an M.S. in Commercial Real Estate and as an MBA concentration.
Robinson's graduate analytics program is No. 11 among public university programs and No. 36 overall. It is offered as an M.S. in Data Science & Analytics and a STEM-designated MBA major in business analysis.
The college's graduate health administration program is No. 21 among public university programs and No. 41 overall. It is offered as a dual-degree MBA/Master of Health Administration and as an MBA concentration. It is ranked with healthcare management programs.
Robinson's part-time MBA is No. 22 among public university programs and No. 35 overall.
'We are pleased and proud of these U.S. News rankings, which reflect the relevance and responsiveness of our programs for working professionals and the esteem of our peer institutions,' said Richard Phillips, dean of the Robinson College.
U.S. News bases its part-time MBA rankings on factors including peer assessment, median GMAT/GRE scores, median GPA, and average length of work experience. Two-hundred sixty-nine part-time programs met the criteria for consideration and were evaluated.
Specialty rankings for information systems, real estate, and data science and analytics programs depend on peer assessments from business school deans and directors of MBA programs accredited by the Association to Advance Collegiate Schools of Business. Healthcare management programs are evaluated by accredited member institutions of the Commission on Accreditation of Healthcare Management Education.
For more information, visit http://usnews.com.
Attachment
Five Georgia State Graduate Business Programs Ranked in 2025 U.S. News Rankings
CONTACT: Holly Frew J. Mack Robinson College of Business 404-413-7076 hfrew@gsu.eduSign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
an hour ago
- Entrepreneur
გამოიწერეთ Wolt+ უფასოდ ერთი წლით - ვოლტის და საქართველოს ბანკის ერთობლივი შეთავაზება
This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link:
Yahoo
3 hours ago
- Yahoo
2 Profitable Stocks on Our Watchlist and 1 to Turn Down
While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity". Not all profitable companies are created equal, and that's why we built StockStory - to help you find the ones that truly shine bright. That said, here are two profitable companies that generate reliable profits without sacrificing growth and one that may face some trouble. Trailing 12-Month GAAP Operating Margin: 8.9% Known for its proprietary D-U-N-S Number that serves as a unique identifier for businesses worldwide, Dun & Bradstreet (NYSE:DNB) provides business decisioning data and analytics that help companies evaluate credit risks, verify suppliers, enhance sales productivity, and gain market visibility. Why Is DNB Risky? 3.7% annual revenue growth over the last two years was slower than its business services peers Day-to-day expenses have swelled relative to revenue over the last five years as its adjusted operating margin fell by 5 percentage points Flat earnings per share over the last four years lagged its peers Dun & Bradstreet's stock price of $9.02 implies a valuation ratio of 8.4x forward P/E. Read our free research report to see why you should think twice about including DNB in your portfolio, it's free. Trailing 12-Month GAAP Operating Margin: 18% Started with the invention of the steam drill, Ingersoll Rand (NYSE:IR) provides mission-critical air, gas, liquid, and solid flow creation solutions. Why Do We Like IR? Operating margin expanded by 13 percentage points over the last five years as it scaled and became more efficient Incremental sales over the last five years have been highly profitable as its earnings per share increased by 17.2% annually, topping its revenue gains IR is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders, and its growing cash flow gives it even more resources to deploy At $83.05 per share, Ingersoll Rand trades at 23.8x forward P/E. Is now a good time to buy? Find out in our full research report, it's free. Trailing 12-Month GAAP Operating Margin: 15.3% Founded in 1999 and receiving its first FDA approval in 2006, DexCom (NASDAQ:DXCM) develops and sells continuous glucose monitoring systems that allow people with diabetes to track their blood sugar levels without repeated finger pricks. Why Is DXCM a Good Business? Existing business lines can expand without risky acquisitions as its organic revenue growth averaged 19.2% over the past two years Performance over the past five years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 23.2% outpaced its revenue gains Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures DexCom is trading at $86.15 per share, or 39.6x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it's free. Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free.
Entrepreneur
5 hours ago
- Entrepreneur
როგორ გაიტანა ქართულმა კომპანია ,,დომუს ალუმინიუმმა" ალუმინის კონსტრუქციები საერთაშორისო ბაზარზე
This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link:
